Efavirenz use and neurocognitive performance among older people living with HIV who were on antiretroviral therapy-Reference-Cited by-同舟云学术

Efavirenz use and neurocognitive performance among older people living with HIV who were on antiretroviral therapy

Published:2019-05-30 Issue:1 Volume:32 Page:12-20
ISSN:0954-0121
Container-title:AIDS Care
language:en
Short-container-title:AIDS Care

Author:

Qin Pei¹²,He Jianmei³,Wang Zixin¹⁴,Chen Xi³,Li Jinghua⁵,Fung Ada Wai Tung⁶^ORCID,Jiang Hui¹,Chen Jie³,Wong Anna¹,Lau Joseph Tak Fai¹⁴⁷^ORCID

Affiliation:

1. Centre for Health Behaviours Research, JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, People’s Republic of China

2. School of Public Health, Shenzhen University Health Science Center, Shenzhen, People’s Republic of China

3. Hunan Provincial Center for Disease Control and Prevention, Changsha, People’s Republic of China

4. Shenzhen Research Institute, The Chinese University of Hong Kong, Shenzhen, People’s Republic of China

5. School of Public Health, Sun Yat-sen University, Guangzhou, People’s Republic of China

6. Department of Applied Social Sciences, the Hong Kong Polytechnic University, Hong Kong SAR, People’s Republic of China

7. Centre for Medical Anthropology and Behavioural Health, Sun Yat-sen University, Guangzhou, People’s Republic of China

Funder

Health and Family Planning Commission in the Hunan Province, China

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Social Psychology,Health (social science)

Link

https://www.tandfonline.com/doi/pdf/10.1080/09540121.2019.1622645

Reference34 articles.

1. Prevalence of cognitive disorders differs as a function of age in HIV virus infection

2. Care of the aging HIV patient

3. Characteristics Associated With Awareness, Perceptions, and Use of Electronic Nicotine Delivery Systems Among Young US Midwestern Adults

5. Efavirenz associated with cognitive disorders in otherwise asymptomatic HIV-infected patients

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz + lamivudine + tenofovir disoproxil among HIV-1 patients newly starting treatment in Hunan Province in China;BMC Infectious Diseases;2023-06-12

2. Antiretroviral drugs efavirenz, dolutegravir and bictegravir dysregulate blood-brain barrier integrity and function;Frontiers in Pharmacology;2023-03-08

3. A qualitative study of older people living with HIV Hong Kong: Resilience through downward comparison amidst limited social support;Journal of Aging Studies;2023-03

4. Treatment persistence of bictegravir/emtricitabine/tenofovir alafenamide and efavirenz+lamivudine+tenofovir disoproxil among HIV-1 patients newly starting treatment in China;2023-01-03

5. Older People Living with HIV Were Less Physically Active Than Their Uninfected Counterparts in China: A Matched-Sample Mediation Analysis;AIDS and Behavior;2022-01-27